# A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

> **NCT03073343** · NA · RECRUITING · sponsor: **Southern California Institute for Research and Education** · enrollment: 48 (estimated)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Non Insulin Dependent Diabetes
- ALT

## Interventions

- **DIETARY_SUPPLEMENT:** Betaine (trimethyglycine)

## Key facts

- **NCT ID:** NCT03073343
- **Lead sponsor:** Southern California Institute for Research and Education
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-11-12
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03073343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03073343, "A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03073343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*